ViewRay Inc Future of Prostate Cancer Radiation Therapy Call Transcript
Okay, everybody. Welcome to our event here on the afternoon of March 16. Welcome on behalf of the ViewRay team to presentation. And we're so happy to welcome 2 key opinion leaders who are renowned clinicians and researchers, and both of them are steeped in terms of utilization on the MRIdian system. So as we begin, I would ask you to please take note of our forward-looking statements and disclaimer on Slide 2.
And with that, let's go ahead and jump in and let me introduce our 2 key opinion leaders who are very well known to the ViewRay team. And they are Dr. Amar Kishan from UCLA; and Dr. Himanshu Nagar from Weill Cornell. Both of these gentlemen are pioneering incredibly important clinical data for customers, for cancer patients and for the company. Dr. Kishan has led both the MIRAGE and SCIMITAR trials. He will talk about the importance and impact of that data on his daily practice and what it means for patients. And similarly, Dr. Nagar is leading 2 very complementary trials in SHORTER and FORT. And we will attempt to be very
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
